Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ezban

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|April 15, 1994
Characterization of chemically crosslinked human factor VIIIaE Persson, M Ezban
The Journal of Biological Chemistry|January 25, 1988
Generation of active coagulation factor VIII from isolated subunitsO Nordfang, M Ezban
Developments in Biological Standardization|January 1, 1980
A new high quality albumin for therapeutic useJ F Hansen, M Ezban
Lancet (London, England)|January 20, 1979
Cryoprecipitate preparationM Ezban, J F Hansen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of actionL V Rao, M Ezban
Journal of Vascular Surgery|February 1, 1997
Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIaB Arnljots, M Ezban, U Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2010
Animal models of FVIIa gene expression: their role in the future development of haemophilia treatmentA Obergfell, T Nichols, M Ezban
Biochemistry|February 12, 1991
Heterogeneity in the tyrosine sulfation of Chinese hamster ovary cell produced recombinant FVIIIJ Mikkelsen, J Thomsen, M Ezban
Journal of Thrombosis and Haemostasis : JTH|January 30, 2009
rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic ratsB Lauritzen, M Tranholm, M Ezban
Thrombosis and Haemostasis|June 24, 1985
Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAgO Nordfang, M Ezban, B Dinesen
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|April 15, 1994
Characterization of chemically crosslinked human factor VIIIaE Persson, M Ezban
The Journal of Biological Chemistry|January 25, 1988
Generation of active coagulation factor VIII from isolated subunitsO Nordfang, M Ezban
Developments in Biological Standardization|January 1, 1980
A new high quality albumin for therapeutic useJ F Hansen, M Ezban
Lancet (London, England)|January 20, 1979
Cryoprecipitate preparationM Ezban, J F Hansen
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of actionL V Rao, M Ezban
Journal of Vascular Surgery|February 1, 1997
Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIaB Arnljots, M Ezban, U Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 6, 2010
Animal models of FVIIa gene expression: their role in the future development of haemophilia treatmentA Obergfell, T Nichols, M Ezban
Biochemistry|February 12, 1991
Heterogeneity in the tyrosine sulfation of Chinese hamster ovary cell produced recombinant FVIIIJ Mikkelsen, J Thomsen, M Ezban
Journal of Thrombosis and Haemostasis : JTH|January 30, 2009
rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic ratsB Lauritzen, M Tranholm, M Ezban
Thrombosis and Haemostasis|June 24, 1985
Reactivity of factor VIII inhibitors in a micro ELISA for factor VIII: CAg and in solid phase immunoisolation of VIII: CAgO Nordfang, M Ezban, B Dinesen
Pageof 9